Apellis Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Apellis Pharmaceuticals shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.7M | 2.5M | 1.50 |
| 2023-09-30 | $1.5M | 1.2M | 1.27 |
| 2023-06-30 | $6.2M | 2.6M | 2.39 |
| 2022-12-31 | $196k | 130k | 1.51 |
| 2022-06-30 | $139k | 93k | 1.49 |
| 2021-12-31 | $4.4M | 2.9M | 1.51 |
| 2021-03-31 | $14M | 9.9M | 1.40 |
| 2020-12-31 | $14M | 8.2M | 1.65 |
| 2020-09-30 | $1.5M | 1.4M | 1.06 |